ASP 8825 - Study in Patients With Painful Diabetic Polyneuropathy

Phase III Clinical Trial of NPB-01maintenance Therapy in Patients With Multifocal Motor Neuropathy.

NCT01827072 ·Status: COMPLETED ·Phase: PHASE3

Evaluate Efficacy and Safety of Fingolimod 0.5 mg Orally Once Daily Versus Placebo in Chronic Inflammatory Demyelinating Polyradiculoneuropathy Patients.

NCT01625182 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

NCT05327114 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

A Clinical Trial to Investigate the Long-term Safety and Tolerability, Efficacy, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of ARGX-117 in Adults With Multifocal Motor Neuropathy

NCT05405361 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Chronic Inflammatory Demyelinating Polyneuropathy

NCT00004772 ·Status: COMPLETED ·Phase: PHASE3

Study of M5049 in DM and PM Participants (NEPTUNIA)

NCT05650567 ·Status: TERMINATED ·Phase: PHASE2

Safety and Efficacy of Avonex in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

NCT00099489 ·Status: COMPLETED ·Phase: PHASE2

The Evaluation of Efficacy and Safety of Rituximab in Refractory CIDP Patients With IgG4 Autoantibodies

NCT03864185 ·Status: COMPLETED ·Phase: PHASE2

Randomized Study of Intravenous Immunoglobulin (IVIg) in Patients With Subacute Proximal Diabetic Neuropathy

NCT00004407 ·Status: TERMINATED ·Phase: NA

Efficacy and Safety Study of GB-0998 for Treatment of Steroid-resistant Polymyositis and Dermatomyositis (PM/DM)

NCT00335985 ·Status: COMPLETED ·Phase: PHASE3

Intravenous Immunoglobulin Therapy for Small Fiber Neuropathy

NCT02637700 ·Status: COMPLETED ·Phase: PHASE2

The Phase I Study of Recombinant Human Nerve Growth Factor Injection

NCT04232332 ·Status: UNKNOWN ·Phase: PHASE1

Proof-of-concept Study for SAR445088 in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

NCT04658472 ·Status: COMPLETED ·Phase: PHASE2

A Study to Assess the Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP, an Autoimmune Disorder That Affects the Peripheral Nerves)

NCT04281472 ·Status: COMPLETED ·Phase: PHASE2

Study of Efficacy and Safety of Canakinumab in Japanese Patients With AOSD

NCT04717635 ·Status: COMPLETED ·Phase: PHASE3

Rituximab in Chronic Inflammatory Demyelinating Polyneuropathy

NCT04480450 ·Status: WITHDRAWN ·Phase: PHASE2

Trial of Efficacy and Safety of NS-229 Versus Placebo in Patients With Eosinophilic Granulomatosis With Polyangiitis

NCT06046222 ·Status: RECRUITING ·Phase: PHASE2

Rituximab to Treat Neuropathy With Anti-MAG Antibodies

NCT00050245 ·Status: COMPLETED ·Phase: PHASE2

Subcutaneous Immunoglobulin Treatment for Multifocal Motor Neuropathy

NCT00268788 ·Status: COMPLETED ·Phase: PHASE2

ACALA-R In Predominantly Demyelinating IgM Mediated Neuropathy

NCT05065554 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Zoledronic Acid or Methylprednisolone for Active Charcot's Neuroarthropathy of Foot in Patients With Diabetes Mellitus

NCT03289338 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Phase II Clinical Trial of NPB-01 in Patients With Anti-aquaporin 4 Antibody Positive Neuromyelitis Optica Spectrum Disorder Not Provided Adequate Effect of Therapy to Steroids Plus Therapy.

NCT01845584 ·Status: COMPLETED ·Phase: PHASE2

Study of Efficacy of ARA 290 on Corneal Nerve Fiber Density and Neuropathic Symptoms of Subjects With Sarcoidosis

NCT02039687 ·Status: COMPLETED ·Phase: PHASE2

A Study of TAK-771 in Japanese Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) and Multifocal Motor Neuropathy (MMN)

NCT05084053 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Daratumumab for Polyneuropathy Associated With MGUS

NCT06046287 ·Status: WITHDRAWN ·Phase: PHASE2